company mission
Very little changed. In both 2014 and 2015, eGenesis described itself the same basic way: a life sciences company developing and commercializing engineered organisms for human health, built on CRISPR-based genome engineering. That is not a mission pivot. It is the same pitch with the commas moved around. The 2015 version adds one extra flourish: backing from leaders in genome engineering and regenerative medicine. That changes the framing, not the mission. The core claim stayed fixed on engineered organisms, human health, and CRISPR as the technical engine. Evidence is thin because there are only two snapshots, eight months apart, and both read like near-copies. So the honest read is boring: stable mission, slight credibility-polish, no meaningful divergence visible from this record.